Clinical trial
Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites…
NCT00389753 · University Hospital, Ghent, Other · Withdrawn
Key facts
| NCT number | NCT00389753 |
|---|---|
| Title | Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure |
| Official title | A Prospective, Randomized, Double Blinded Controlled Clinical Trial of the Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure |
| Lead sponsor | University Hospital, Ghent, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Hydration of Scars |
| Intervention type | Drug |
| Interventions | Application of Aruba Aloë formula F-BC-096 or control |
| Enrollment | 0 |
| First posted | Oct 19, 2006 |
| Last update posted | Jul 2, 2021 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: